2016
DOI: 10.1590/1516-4446-2015-1721
|View full text |Cite
|
Sign up to set email alerts
|

The putative catalytic role of higher serotonin bioavailability in the clinical response to exposure and response prevention in obsessive-compulsive disorder

Abstract: Objective: Exposure and response prevention (ERP) is effective to treat obsessive-compulsive disorder (OCD), but the lack of tolerance to the aversion nature of exposure techniques results in a high drop-out rate. There have been reports of a generic stress endurance effect of serotonin (5-HT) in the central nervous system (CNS) which might be explained by suppression of defensive fixed action patterns. Previous studies have proposed that higher baseline 5-HT concentration and slow decrease in concentration du… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…This conclusion is consistent with the accepted practice that exposure therapy is an essential component of treatment for phobic avoidance disorders [ 13 ]. Therefore, experiencing and mastering aversion during exposure procedures is, putatively, a core element of CBT effectiveness [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…This conclusion is consistent with the accepted practice that exposure therapy is an essential component of treatment for phobic avoidance disorders [ 13 ]. Therefore, experiencing and mastering aversion during exposure procedures is, putatively, a core element of CBT effectiveness [ 14 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, many inconsistencies have made it difficult to isolate specific abnormalities within the serotonergic system. For example, OCD patients and healthy controls show similar levels of plasma serotonin and cerebrospinal serotonin and metabolites [29][30][31], but recent work indicates that plasma serotonin concentration is positively correlated with OCD symptom reduction [30]. In addition, agonists can reduce or exacerbate OCD symptoms depending on the drug's receptor subtype affinity [28,31].…”
Section: (B) Evidence From Clinical Obsessive-compulsive Disorder Studies Suggests Dysfunction In Monoaminergic Systemsmentioning
confidence: 99%